# Effect of Four Different Diagnostic Eye Drops on Tear Film Thickness

> **NCT07230548** · PHASE3 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 20 (actual)

## Conditions studied

- Ocular Surface Disease
- Tear Film Characteristics

## Interventions

- **DRUG:** Oxybuprocaine MDU
- **DRUG:** Oxybuprocaine SDU
- **DRUG:** Oxybuprocaine/fluorescein SDU
- **DRUG:** Fluorescein SDU

## Key facts

- **NCT ID:** NCT07230548
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-10
- **Primary completion:** 2020-10-28
- **Final completion:** 2020-10-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07230548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07230548, "Effect of Four Different Diagnostic Eye Drops on Tear Film Thickness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07230548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*